Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-039-2 | CAS number: 65997-03-7 The low boiling fraction obtained by the distillation of tall oil. Contains fatty acids such as palmitic, stearic, oleic and linoleic as well as neutral materials.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- 1992/01/28-1992/02/22
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to the appropriate OECD test guideline, and in compliance with GLP using a related test substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- Tall oil
- EC Number:
- 232-304-6
- EC Name:
- Tall oil
- Cas Number:
- 8002-26-4
- IUPAC Name:
- 8002-26-4
- Details on test material:
- - Name of test material (as cited in study report): Bevacid 25/30, Distilled Tall Oil
- Physical state: Yellowish - brown liquid
- Storage condition of test material: Room temperature in the dark
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: D.Hall, Newchurch, Staffordshire, England.
- Age at study initiation: 6-7 weeks
- Weight at study initiation: 301-370g
- Housing: The animals were housed in groups of ten in suspended metal cages with wire mesh floors.
- Diet: A vitamin C enriched quinea-pig diet FD1, ad libitum
- Water: ad libitum
- Acclimation period: 12 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): ca/ 21
- Humidity (%): 30-70
- Air changes (per hr): ca. 15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: Alembicol D
- Concentration / amount:
- Induction injection 1. FCA diluted with an equal volume of water for irrigation.
Induction injection 2. Bevacid 25/30, 7.5% v/v in Alembicol D
Induction injection 3. Bevacid 25/30, 7.5% v/v in a 50:50 mixture of FCA and Alembicol D.
Topical challenge - As supplied and 50% v/v in Alembicol D.
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Alembicol D
- Concentration / amount:
- Induction injection 1. FCA diluted with an equal volume of water for irrigation.
Induction injection 2. Bevacid 25/30, 7.5% v/v in Alembicol D
Induction injection 3. Bevacid 25/30, 7.5% v/v in a 50:50 mixture of FCA and Alembicol D.
Topical challenge - As supplied and 50% v/v in Alembicol D.
- No. of animals per dose:
- 6 animals were used for the preliminary investigations, 20 animals in the control group and 20 as test animals.
- Details on study design:
- RANGE FINDING TESTS: The intradermal and topical irritancy of a range of dilutions of the test substance was investigates to identify where possible a) concentrations of the test substance that will produce irritation suitable for the induction phase of the main study and b) a maximum non-irritant concentration by the topical route of administration for the challenge phase. Based on the results of the preliminary investigations, the following concentrations of the test substance were selsected;
Induction intradermal injection - 7.5% in Alembicol D
Induction topical application - As supplied. This was the maximum concentration and did not give rise to irritating effects.
Topical challenge - As supplied and 50% v/v in Alembicol D. From preliminary investigations as supplied was the maximum concentration and did not give rise to irritating effects.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2. With treatment with 10% w/w sodium lauryl sulphate in petrolatum in between the initial induction injection and the final topical application (which was with a patch saturated in Bevacid 25/30 as supplied.)
- Test groups: Bevacid 25/30 in Alembicol/FCA
- Control group: The control animals were treated similarly to the test animals with the exception that the test substance was omitted from the intradermal injections and topical application.
- Site: Dorsal skin on the scapular region
- Frequency of applications: Day 1 (injection), Day 6 (pre-treatment with sodium lauryl sulphate in petrolatum) followed by 24 hours later by a saturated patch firmly secured by elastic adhesive bandage, left in place for 48 hours.
- Duration: 0-14 day
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: Day 14
- Exposure period: 24 hours
- Test groups: Bevacid 25/30, as supplied and 50% v/v in Alembicol D
- Control group: Same as test animals but without test substance.
- Site: anterior site on the flank
- Evaluation (hr after challenge): 24, 48 and 72 hours after removal of the patches.
- Challenge controls:
- 20 animals were designated as challenge controls. They were challenged topically two weeks after the topical induction application using Bevacid 25/30, as supplied and 50% v/v in Alembicol D.
- Positive control substance(s):
- yes
- Remarks:
- formalin
Results and discussion
- Positive control results:
- Historical data for the positive control (formalin) confirmed the suitability of the test system.
Any other information on results incl. tables
Clinical signs: No signs of ill health or toxicity were recorded.
Induction:
Intradermal injections: Necrosis was recorded at sites receiving FCA in test and control animals. Irritation was seen in test animals at sites receiving Bevacid 25/30, 7.5% v/v in Alembicol D and slight irritation was observed in control animals receiving Alembicol D. Topical application: Slight erythema was observed in test animals following topical application with Bevacid 25/30, as supplied. Very slight erythema was seen in the control guinea-pigs.
Challenge:
The dermal responses seen in the test animals were similar to those of the controls.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Distilled Tall Oil (Bevacid 25/30) was found to be not sensitising in a reliable study conducted according to an appropriate test protocol, and in compliance with GLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)